beyond spring stock forecast

The Actual Price is not adjusted for splits or dividends. BeyondSpring Inc a clinical stage biopharmaceutical company together with its subsidiaries focuses on the development of cancer therapies.

Iot News State Of Iot 2022 Number Of Connected Iot Devices Growing 18 To 14 4 Billion Globally Iot Business News

The Score for BYSI is 15 which is 70 below its historic median.

. TOGETHER WERE MAKING A. The BeyondSpring stock prediction results are shown below and presented as a graph table and text information. For BeyondSpring stock forecast for 2025 12 predictions are.

TOGETHER WERE MAKING ADIFFERENCE IN CANCER TREATMENT. Get free stock tools free stock ratings free stock charts and calculate the value of stocks to buy. The average BeyondSpring stock forecast 2023 represents a -089 decrease from the last price of 0810999989509583.

In the first half of 2022 Beyond Meats revenue fell 04 year-over-year. According to 7 analysts the average rating for BYSI stock is Sell The 12-month stock price forecast is 235 which is an increase of 21329 from the latest price. EPS forecast this quarter-023.

If you are looking for stocks with good return BeyondSpring Inc. Annual profit last year-642M. Beyondspring stock price prediction is an act of determining the future value of Beyondspring shares using few different conventional methods such as EPS.

Real-time trade and investing ideas on BeyondSpring Inc BYSI from the largest community of traders and investors. Today - Cloudy with a high of 73 F 228 C and a 71 chance of precipitation. USD 065 001 152.

Is BeyondSpring Stock Undervalued. View US markets world markets after hours trading quotes and other important stock market activity. The current BeyondSpring BYSI share price is 075.

Winds variable at 14 to 19 mph 225 to 306 kph. The treatment landscape is changing. On average 2 Wall Street analysts forecast BYSIs revenue for 2023 to be 647560011 with the lowest BYSI revenue forecast at 58391345 and the highest BYSI revenue forecast at.

The companys lead asset is the Plinabulin a selective immune-modulating microtubule-binding agent that has completed Phase III clinical trials for the prevention of chemotherapy-induced neutropenia. Trefis estimates BYNDs Q3 2022 revenues to be around 98 Mil matching the consensus estimate. According to the issued ratings of 5 analysts in the last year the consensus rating for BeyondSpring stock is Hold based on the current 1 sell rating 3 hold ratings and 1 buy.

DIFFERENCE IN CANCER TREATMENT. And for treatment of later. The overnight low will be 66 F 189 C.

Annual revenue last year 14M. BeyondSpring stock forecasts are adjusted once a day. The Closing Price Days High Days Low and Days Volume have been adjusted to account for any stock splits andor dividends which may have occurred for this security since the date shown above.

Stock market data coverage from CNN.

The 15 Best Value Stocks To Buy Right Now Kiplinger

Tesla Stock Forecast Price Prediction For 2022 2023 2025 And Beyond Litefinance

Fall Winter Spring 2021 22 Outlook Archive Wlfi Com

10 Top Stock Market Predictions For 2023 Investorplace

2022 Outlook Stocks Bonds And More Charles Schwab

Bysi Stock Forecast Price News Beyondspring

Asia Forecast Key Trends In 2022 Center For Strategic And International Studies

Price Action Trading Strategies 6 Patterns That Work Tradingsim

Stock Market Predictions 3 To 6 Month Forecast 2022 2023 Outlook

Stock Market Outlook 2022 Fed Rate Hikes Wall Street Forecasts

Beyondspring Axes 35 Of Us Staff After November Drug Rejection Fierce Biotech

Global Fleet And Mro Market Forecast 2021 2031

Beyondspring Stock Forecast Down To 0 000001 Usd Bysi Stock Price Prediction Long Term Short Term Share Revenue Prognosis With Smart Technical Analysis